BBT002 for COPD and Chronic Rhinosinusitis
A Study of BBT002 in Healthy Volunteers (HVs) and in Adult Patients With Chronic Obstructive Pulmonary Disease (COPD) or Chronic Rhiosininusitis With Nasal Polyps (CRSwNP)
- Age
- 18 – 80
- Sex
- Any
- Trial phase
- Phase 1
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 286 (estimated)
- Sponsor
- Bambusa Therapeutics · Industry
This trial is looking for healthy volunteers and adults with COPD or chronic rhinosinusitis with nasal polyps. Participants will take a medication called BBT002 and be monitored for effects.
You may be able to join if
- I am between 18 and 65 years old if I am a healthy volunteer.
- I am between 35 and 80 years old if I have COPD.
- I am between 18 and 80 years old if I have chronic rhinosinusitis with nasal polyps.
- I have a body mass index within the acceptable range.
- I am willing to avoid alcohol 24 hours before each visit.
- I am a non-smoker or an occasional smoker.
- I am using adequate contraception if I can have children.
- I do not have significant medical issues or diseases.
You may not be able to join if
- I have tested positive for HIV, hepatitis C, or hepatitis B.
- I have an autoimmune disease or cancer.
- I have a history of major health problems.
- I have abnormal lab results or vital signs.
- I have a history of drug or alcohol abuse in the past 2 years.
- I have severe allergies or hypersensitivity.
- I currently have other serious lung diseases.
- I am unable to perform lung function tests.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your EligibilityRandomized study of single and multiple doses of BBT002 in healthy volunteers and in adult patients with chronic obstructive pulmonary disease (COPD) or chronic rhinosinusitis with nasal polyps (CRSwNP).
Loading trial locations…